РЕЦИДИВИРОВАНИЕ МЫШЕЧНО-НЕИНВАЗИВНОГО РАКА МОЧЕВОГО ПУЗЫРЯ: ВОЗМОЖНЫЕ ЭНДОСКОПИЧЕСКИЕ ПУТИ РЕШЕНИЯ ПРОБЛЕМЫ
https://doi.org/10.17650/1726-9776-2010-6-1-6-13
Аннотация
The high rate of recurrences after transurethral resection of the bladder is a key problem in the treatment of patients with superficial tumors. The main reasons for the high rate of recurrences are diffuse urothelial neoplastic changes, cancer in situ, possible tumor cell implantation at surgery, and non-radical removal of a tumor itself. As of now, the most important ways of solving the problem, among which there are a lot of endoscopic modes, include increased radicality of primary tumor removal (bipolar electrosurgery, electrovaporization, laser resection and ablation), more precise intraoperative disease staging (Raman spectroscopy, optical coherence tomography), identification of invisible neoplasms by standard methods (photodynamic diagnosis, narrow-spectrum imaging), monitoring of primary tumor removal radicality (early recystoscopy and bladder biopsy), photodynamic therapy, urinary retention elimination, by saving the patient from infravesical obstruction, as well as urinary cytology, use of diagnostic markers (BTA test and others), adjuvant immunochemotherapy, radiotherapy, etc. By taking into account the data available in the literature and their findings, the authors consider possible ways of reducing the recurrence rate of superficial bladder carcinoma.
Ключевые слова
Об авторах
А. Г. Мартов
Городская клиническая урологическая больница № 47 Департамента здравоохранения Москвы
Россия
Россия
Д. В. Ергаков
Городская клиническая урологическая больница № 47 Департамента здравоохранения Москвы
Россия
Россия
А. С. Андронов
Городская клиническая урологическая больница № 47 Департамента здравоохранения Москвы
Россия
Россия
Список литературы
1. Avritscher E.B., Cooksley C.D.,Grossman H.B. et al. Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology 2006;68:549-53.
2. Bryan R.T., Wallace D.M.A. 'Superficial' bladder cancer -time to uncouple pT1 tumours from pTa tumours. BJU Int 2002;90:846-52.
3. Матвеев Б.П. Рак мочевого пузыря. В кн.: Клиническая онкоурология. Под ред. Б.П. Матвеева. М.: Вердана, 2003. с. 197-406.
4. Wang D.S., Bird V.G., Leonard V.Y. et al. Use of bipolar energy for transurethral resection of bladder tumors: pathologic considerations. J Endourol 2004;18(6):578-82.
5. Pu X.Y., Wang H.P., Wu Y.L. et al. Use of bipolar energy for transurethral resection of superficial bladder tumors: long-term results. J Endourol 2008;22(3):545-9.
6. Лопаткин Н.А., Мартов А.Г.,Гущин Б.Л. и др. Электровапоризация в лечении рака мочевого пузыря. Урол нефрол 1998;(5):9-12.
7. Zhu Y., Jiang X, Zhang J. et al. Safety and efficacy of holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresection: single-center experience. Urology 2008;72(3):608-12.
8. Crow P., Uff S., Farmer J.A. et al. The use of Raman spectroscopy to identify and characterize transitional cell carcinoma in vitro. BJU Int 2004;93(9):232-6.
9. Manyak M.J., Gladkova N.D.,Makari J.H. et al. Evaluation of superficial bladder transitional-cell carcinoma by optical coherence tomography. J Endourol 2005;19(5):570-4.
10. Lerner S.P., Goh A.C., Tresser N.I.,Shen S.S. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer. Urology 2008;72(11):133-7.
11. Lingley-Papadopoulos C.A.,Loew M.H., Manyak M.J., Zara J.M. Computer recognition of cancer in the urinary bladder using optical coherence tomography and texture analysis. J Biomed Opt 2008;13(2):024003.
12. Крупин В.Н., Стрельцова О.С. Рак мочевого пузыря, проблемы и перспективы. Ремедиум-Приволжье 2005;(5):65-72.
13. Jocham D., Stepp H., Waidelich R. Photodynamic diagnosis in urology: Stateof-the-art. Eur Urol 2008;53(6): 1138-50.
14. Daniltchenko D.I., Riedl C.R.,Sachs M.D. et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 2005;174(6):2129-33.
15. Bryan R.T., Billingham L.J.,Wallace D.M. Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int 2008;101(6):702-6.
16. Herr H.W., Donat S.M. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int 2008;102(9):1111-4.
17. Мартов А.Г., Максимов В.А.,Андронов А.С., Ергаков Д.В. Возможности узкоспектровой фиброцистоскопии в диагностике рака мочевого пузыря. Урология 2009 (в печати).
18. Schulze M., Stotz N., Rassweiler J. Retrospective analysis of transurethral resection, second-look resection, and longterm chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach. J Endourol 2007;21(12):1533-41.
19. Лопаткин Н.А., Мартов А.Г.,Гущин Б.Л. и др. Диагностика и лечение рецидивного поверхностного рака мочевого пузыря с помощью ранней повторной цистоскопии и биопсии мочевого пузыря. Урология 2003;(5):45-9.
20. Grimm M.-O., Steinhoff Ch.,Simon X. et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003;170:433-7.
21. Bailey M.J. Urinary marker's in bladder cancer. BJU Int 2003;91(9):772-3.
22. Sylvester R.J., van der Meijden A.P.M.,Oosterlinck W. et al. Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-77.
23. Sylvester R., Oosterlinck W., van der Meijden A. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a metaanalysis of published results of randomized clinical trials. J Urol 2004;171:2186-90.
24. Huncharek M., Kupelnick B. The influence of intravesical therapy on progression of superficial transitional cell carcinoma of the bladder: a metaanalytic comparison of chemotherapy versus bacilli Calmette-Guerin immunotherapy. Am J Clin Oncol 2004;27:522-8.
25. Berger A.P., Steiner H., Stenzl A. et al. Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study. Urology 2003;61: 338-41. 26. Van der Heijden A.G., Kiemeney L.A.,
26. Gofrit O.N. et al. Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur Urol 2004;46:65-72. 27. Di Stasi S.M., Giannantoni A.,
27. Giurioli A. et al. Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial. Lancet Oncol 2006;7:43-51.
28. Witjes J.A. Management of BCG failures in superficial bladder cancer: a review. Eur Urol 2006;49:790-7.
29. Карагужин С.Г., Меринов Д.С.,Мартов А.Г. Одномоментная комбинированная трансуретральная резекция мочевого пузыря и простаты при сочетании поверхностного рака мочевого пузыря и аденомы простаты. Урология 2005;(5):17-21.
Рецензия
Для цитирования:
Мартов А.Г., Ергаков Д.В., Андронов А.С. РЕЦИДИВИРОВАНИЕ МЫШЕЧНО-НЕИНВАЗИВНОГО РАКА МОЧЕВОГО ПУЗЫРЯ: ВОЗМОЖНЫЕ ЭНДОСКОПИЧЕСКИЕ ПУТИ РЕШЕНИЯ ПРОБЛЕМЫ. Онкоурология. 2010;6(1):6-13. https://doi.org/10.17650/1726-9776-2010-6-1-6-13
For citation:
Martov A.G., Ergakov D.V., Andronov A.S. RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER: POSSIBLE ENDOSCOPIC MODES TO SOLVE THE PROBLEM. Cancer Urology. 2010;6(1):6-13. (In Russ.) https://doi.org/10.17650/1726-9776-2010-6-1-6-13
Просмотров:
782
Послать статью по эл. почте 
